Type 2 responses determine skin rash during recombinant interleukin-2 therapy. - Sommer, Charline; Neuhaus, Vanessa; Gogesch, Patricia; Flandre, Thierry; Dehmel, Susann; Sewald, Katherina (Journal of Immunotoxicology, 2024)